citalopram has been researched along with Asperger Syndrome in 4 studies
Citalopram: A furancarbonitrile that is one of the serotonin uptake inhibitors used as an antidepressant. The drug is also effective in reducing ethanol uptake in alcoholics and is used in depressed patients who also suffer from TARDIVE DYSKINESIA in preference to tricyclic antidepressants, which aggravate dyskinesia.
citalopram : A racemate comprising equimolar amounts of (R)-citalopram and its enantiomer, escitalopram. It is used as an antidepressant, although only escitalopram is active.
1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile : A nitrile that is 1,3-dihydro-2-benzofuran-5-carbonitrile in which one of the hydrogens at position 1 is replaced by a p-fluorophenyl group, while the other is replaced by a 3-(dimethylamino)propyl group.
Asperger Syndrome: A disorder beginning in childhood whose essential features are persistent impairment in reciprocal social communication and social interaction, and restricted, repetitive patterns of behavior, interests, or activities. These symptoms may limit or impair everyday functioning. (From DSM-5)
| Excerpt | Relevance | Reference |
|---|---|---|
| "To determine the efficacy and safety of citalopram hydrobromide therapy for repetitive behavior in children with autism spectrum disorders." | 9.14 | Lack of efficacy of citalopram in children with autism spectrum disorders and high levels of repetitive behavior: citalopram ineffective in children with autism. ( Anagnostou, E; Bregman, JD; Donnelly, CL; Dukes, K; Hirtz, D; Hollander, E; King, BH; McCracken, JT; Ritz, L; Scahill, L; Sikich, L; Sullivan, L; Wagner, A, 2009) |
| "To determine the efficacy and safety of citalopram hydrobromide therapy for repetitive behavior in children with autism spectrum disorders." | 5.14 | Lack of efficacy of citalopram in children with autism spectrum disorders and high levels of repetitive behavior: citalopram ineffective in children with autism. ( Anagnostou, E; Bregman, JD; Donnelly, CL; Dukes, K; Hirtz, D; Hollander, E; King, BH; McCracken, JT; Ritz, L; Scahill, L; Sikich, L; Sullivan, L; Wagner, A, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| King, BH | 2 |
| Dukes, K | 2 |
| Donnelly, CL | 2 |
| Sikich, L | 2 |
| McCracken, JT | 2 |
| Scahill, L | 2 |
| Hollander, E | 2 |
| Bregman, JD | 2 |
| Anagnostou, E | 2 |
| Robinson, F | 1 |
| Sullivan, L | 2 |
| Hirtz, D | 2 |
| Yalcin, O | 1 |
| Wagner, A | 1 |
| Ritz, L | 1 |
| Namerow, L | 1 |
| Thomas, P | 1 |
| Bostic, JQ | 1 |
| Prince, J | 1 |
| Monuteaux, MC | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Citalopram Treatment in Children With Autism Spectrum Disorders and High Levels of Repetitive Behavior[NCT00086645] | Phase 2 | 149 participants (Actual) | Interventional | 2004-04-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 trials available for citalopram and Asperger Syndrome
| Article | Year |
|---|---|
Baseline factors predicting placebo response to treatment in children and adolescents with autism spectrum disorders: a multisite randomized clinical trial.
Topics: Adolescent; Asperger Syndrome; Child; Child Development Disorders, Pervasive; Child, Preschool; Cita | 2013 |
Lack of efficacy of citalopram in children with autism spectrum disorders and high levels of repetitive behavior: citalopram ineffective in children with autism.
Topics: Adolescent; Asperger Syndrome; Attention; Autistic Disorder; Child; Child Development Disorders, Per | 2009 |
2 other studies available for citalopram and Asperger Syndrome
| Article | Year |
|---|---|
Micturition difficulty and urinary retention associated with aripiprazole and citalopram treatment in a male adolescent with Asperger syndrome.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Asperger Syndrome; Citalopram; Humans; Male; Piperaz | 2014 |
Use of citalopram in pervasive developmental disorders.
Topics: Adolescent; Antidepressive Agents, Second-Generation; Asperger Syndrome; Autistic Disorder; Child; C | 2003 |